VASTox joins European research consortium to target the development of new treatments for cancer
Research will focus on Cancer Stem Cells as target for new therapies
19-Jan-2007 -
VASTox announced that it has become a partner in a new European consortium that will undertake research towards developing new treatments for cancer. The research programme, called Targeting Cancer Stem Cells for Therapy, will be backed by a EUR2 million grant from the European Commission under ...
breast cancer
cancer stem cells
Italy
+2